Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 31 points (0.2%) at 16,453 as of Friday, March 7, 2014, 12:15 PM ET. The NYSE advances/declines ratio sits at 1,178 issues advancing vs. 1,746 declining with 171 unchanged.

The Health Services industry currently sits down 0.4% versus the S&P 500, which is unchanged. Top gainers within the industry include Opko Health ( OPK), up 2.8%, DENTSPLY International ( XRAY), up 1.6% and Grifols ( GRFS), up 1.0%. On the negative front, top decliners within the industry include Smith & Nephew ( SNN), down 1.8%, Agilent Technologies ( A), down 1.3% and St Jude Medical ( STJ), down 1.0%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Cooper Companies ( COO) is one of the companies pushing the Health Services industry higher today. As of noon trading, Cooper Companies is up $7.67 (5.9%) to $137.76 on heavy volume. Thus far, 777,410 shares of Cooper Companies exchanged hands as compared to its average daily volume of 524,400 shares. The stock has ranged in price between $133.00-$145.34 after having opened the day at $136.65 as compared to the previous trading day's close of $130.09.

The Cooper Companies, Inc. operates as a medical device company worldwide. Cooper Companies has a market cap of $6.3 billion and is part of the health care sector. Shares are up 5.7% year-to-date as of the close of trading on Thursday. Currently there are 7 analysts who rate Cooper Companies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Cooper Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cooper Companies Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Laboratory Corporation of America Holdings ( LH) is up $1.34 (1.4%) to $95.39 on light volume. Thus far, 434,556 shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $94.18-$95.40 after having opened the day at $94.49 as compared to the previous trading day's close of $94.05.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corporation of America Holdings has a market cap of $8.0 billion and is part of the health care sector. Shares are up 2.4% year-to-date as of the close of trading on Thursday. Currently there are 5 analysts who rate Laboratory Corporation of America Holdings a buy, 2 analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Laboratory Corporation of America Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Quest Diagnostics ( DGX) is up $0.50 (0.9%) to $52.90 on light volume. Thus far, 419,724 shares of Quest Diagnostics exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $52.60-$53.02 after having opened the day at $52.66 as compared to the previous trading day's close of $52.40.

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. Quest Diagnostics has a market cap of $7.5 billion and is part of the health care sector. Shares are down 2.7% year-to-date as of the close of trading on Thursday. Currently there are 2 analysts who rate Quest Diagnostics a buy, 4 analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Quest Diagnostics as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, notable return on equity, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Quest Diagnostics Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null